Investors should be wary of overvalued stocks. Although they may continue to experience share price appreciation, they have a more substantial potential for a rapid decline than other companies trading closer to the sector average. Overvalued stocks are best for investors to strongly consider their upside potential before investing to prevent unneeded portfolio losses. Below,
0 Comments
I love Qualcomm (NASDAQ:QCOM). Based in San Diego, Qualcomm develops and commercializes a range of foundational technologies for the wireless industry. With mobile connectivity becoming an increasingly vital concept, the company’s specialized semiconductor products command tremendous prominence. However, as great as Qualcomm stock is, the market is the ultimate arbiter. Right now, the market is
0 Comments
Palantir (NYSE:PLTR) has delivered growth and advancement at its recent AIPCon event that moved Palantir stock. It has unveiled new customers and product announcements pointing to the company’s fundamental strength. Nearly 70 clients discussed the sharp utilization of Palantir’s Artificial Intelligence Platform. These clients include United Airlines (NASDAQ:UAL), Nebraska Medicine, and AARP.  This reflects the company’s expanding
0 Comments
Real estate investment trusts (REITs) represent one of the best ways to get exposure to investing in real estate without having to take on the risks and capital expenditures of purchasing your own property. When buying into a REIT, investors are essentially giving their money as a loan to a capital management firm, which then
0 Comments
Representation of Ethereum, with its native cryptocurrency ether. Dado Ruvic | Reuters The Securities and Exchange Commission appears to have given the green light for exchange traded funds that hold ether, the world’s second-largest cryptocurrency. Trading is expected to begin as soon as Tuesday. Several fund issuers submitted additional registration statements on Monday afternoon, and
0 Comments
Gene editing stocks represent one of the biggest investing trends in biopharma in recent years. The gene editing field employs advanced technologies to edit the DNA of different organisms, thereby opening up possibilities for transformative treatment options. The most popular tool in the niche is CRISPR-Cas9, which has been touted for its precision, speed, and
0 Comments
The market has sustained a prolonged rally in recent months, supported by optimism and improving economic indicators like robust consumer spending. However, in recent days we have seen a shift as many overvalued stocks have started pulling back, with investors increasingly favoring value over high-flyers. This applies to industrial stocks, too. The industrial sector, while
0 Comments
We’re still early in the second-quarter earnings cycle. So far, it has mostly been the banks and credit card companies that have reported Q2 results. Earnings from the mega-cap technology names are on deck next. However, FactSet reports that with 14% of S&P 500 companies having announced Q2 numbers, 80% have reported better-than-expected profits and
0 Comments
Investors could benefit from ditching these three problematic coal stocks now, given recent developments in wind energy. All countries are developing policies to enhance the shift towards renewable energy sources. In the U.S., the Inflation Reduction Act (IRA) has provided significant tax credits and incentives for wind energy projects. In the same manner, Europe’s REPowerEU
0 Comments
Investing in the stock market is always a gamble, and some risky stocks present an unusually high level of volatility, potentially outweighing any possible returns. The S&P 500 and Nasdaq have reported excellent year-to-date (YTD) gains. However, this bullish outlook can mask underlying pitfalls in high-risk stocks that are unlikely to withstand turbulent markets. Although
0 Comments